GALVESTON, Texas, November 18, 2024--(BUSINESS WIRE)--Chrysalis BioTherapeutics, Inc., a clinical stage biopharmaceutical company developing Chrysalin as a Medical Countermeasure and for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback